Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Tests to Determine Best Chemotherapy

By MedImaging staff writers
Posted on 07 Feb 2005
By combining two methods for evaluating the effectiveness of anticancer chemotherapy, researchers have developed a rapid and sensitive system for selecting the most appropriate drug for an individual patient.

Investigators at the Yale School of Medicine (New Haven, CT, USA) have combined their apoptosis assay with the commercially available ChemoFX assay offered by Precision Therapeutics, Inc. More...
(Pittsburgh, PA, USA).

The ChemoFX assay determines whether a drug will stop tumor growth. Tumor cells are removed during a surgical or biopsy procedure, and the tumor-derived cells are grown in tissue culture. The cells are then treated with anticancer drugs, and the amount of tumor-derived cells killed by each drug is determined. The Yale apoptosis assay measures the ability of the drug to stimulate the process of cell death.

"These two new assays will take the guesswork out of cancer treatment,” explained Dr. Gil Mor, associate professor of obstetrics, gynecology and reproductive sciences at Yale School of Medicine. "In patients with very limited time left to live, six months can feel like an eternity when they may have to start a whole new course of treatment if it proves ineffective. This test will help physicians predict whether a patient will respond to a specific drug, much like they test bacteria for sensitivity to antibiotics.”




Related Links:
Yale School of Medicine
Precision Therapeutics, Inc.

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Digital X-Ray Detector Panel
Acuity G4
OR Table Accessory
Angular Accessory Rail
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.